Bluebird Bio's gene therapy for neurological disorder gets F…
페이지 정보
본문
June 9 (Reuters) - Advisers to the U.S. Food and Drug Administration on Thursday voted to recommend approval of BlueBird Bank Accounnt - bestvccstorecom bio's treatment for a rare neurological disorder, bringing it closer to becoming the third gene therapy to be available in the United States.
All 15 committee members voted unanimously that the benefits of elicel for treatment of cerebral adrenoleukodystrophy (CALD) in patients below 18 years who do not have a matched sibling for stem cell transplant, outweigh its risks.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Sriraj Kalluvila)
- 이전글20 Best Tweets Of All Time Concerning Mini Key Fob Replacement 24.10.18
- 다음글Is There A Place To Research Asbestos Mesothelioma Attorney Online 24.10.18
댓글목록
등록된 댓글이 없습니다.